RxDoctor Payments DataLook up a doctor →

Mark Kutner, MD

Internal Medicine · Miami, FLNPI 1104875277

Payments from drug & device makers

$35,732,920in general payments, 2019–2025

Across 2,806 payments — averaging $12,734 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$11.6M
  • Modernatx, Inc.$8.7M
  • Bavarian Nordic A/s$4.7M
  • Janssen Research & Development, LLC$2.2M
  • Johnson & Johnson$2M
  • Pfizer$1.2M
  • plus $5.3M from 54 others
$263,196in research payments, 2019–2025

Across 33 payments — averaging $7975.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$254K
  • Valneva Austria GmbH$7K
  • Sanofi Pasteur Inc.$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly272$11,622,991
Modernatx, Inc.726$8,678,732
Bavarian Nordic A/s70$4,690,034
Janssen Research & Development, LLC181$2,205,714
Johnson & Johnson57$2,021,156
Pfizer184$1,197,366
Novartis27$1,154,304
Boehringer Ingelheim96$1,018,582
GSK122$700,478
Astrazeneca UK Limited5$621,384
Merck30$600,052
Sanofi Pasteur Inc.43$494,244
Novavax Inc15$182,876
Jazz Pharmaceuticals Inc.93$151,208
Amgen86$67,501
Genentech, Inc.24$63,139
Teva Pharmaceuticals USA, Inc.19$60,177
Valneva Austria GmbH5$46,897
Boehringer Ingelheim International GmbH93$44,921
Shionogi Inc3$25,394
Radius Health, Inc.45$21,736
AbbVie(2 entities)56$15,583
Hoffmann-la Roche Limited4$12,450
Novo Nordisk AS5$10,720
Eli Lilly Export S.A. Puerto Rico Branch4$10,408
Sanofi US Services Inc.2$3,127
Novo Nordisk115$2,338
Lilly USA, LLC116$1,866
AstraZeneca41$1,734
Bayer30$677
Amarin Pharma, Inc.13$539
Antares Pharma, Inc.28$534
Exact Sciences18$429
Abbott17$323
Dexcom, Inc.9$279
Nestle Healthcare Nutrition Inc.18$275
Sumitomo Pharma America, Inc.11$261
Astellas Pharma US Inc9$239
Biohaven Pharmaceuticals, Inc.7$150
Kowa Pharmaceuticals America, Inc.6$116
Corcept Therapeutics5$112
Idorsia Pharmaceuticals US Inc6$111
Takeda Pharmaceuticals U.S.A., Inc.7$106
Sunovion Pharmaceuticals Inc.4$92
Averitas Pharma Inc.3$88
Phathom Pharmaceuticals, Inc.4$87
Esperion Therapeutics, Inc.4$87
Ardelyx, Inc.5$87
Currax Pharmaceuticals LLC6$83
Insmed, Inc.4$82
Inspire Medical Systems, Inc.2$82
Baxter Healthcare4$75
Verona Pharma, Inc.4$74
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$69
Biohaven Pharmaceutical Holding Company Ltd.3$60
Alnylam Pharmaceuticals Inc.2$57
Halozyme Inc3$57
Sanofi-aventis U.S. LLC3$51
Phadia US Inc.3$46
Viatris Specialty LLC2$46

How this compares

$35,732,920 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$77,978
Medicare patients
149
Services billed
1,050

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →